Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness &

Status Recruiting

Clinical Trial Summary

Post-intensive care syndrome (PICS) encompasses persistent physical, cognitive, and psychiatric symptoms following ICU discharge, commonly triggered by serious conditions such as respiratory failure, sepsis, and mechanical ventilation. PICS prevalence is reported to be as high as 84% up to 12 months in patients with at least 2 days spent in the ICU or with mechanical ventilatory support. As a consequence, many patients do not return to they former level of function for weeks, months and even years. Muscular affection manifested by muscle weakness is particularly seen and is provoked by a combination of damage to the nerves or directly the muscles fibers. This affection is referred to as CU-Acquired Weakness (ICUAW). One third of the time, lower extremities are affected, often due to prolonged immobilization or sedation. Evidence suggests that early mobilization reduces the incidence of ICUAW at discharge and improves the number of patients able of stand. However achieving this early intervention is not always feasible due to time or personnel constraints. The purpose of the study is to examine the effectiveness of lower extremity neuromodulation for prevention of muscle deconditioning in patients admitted to the ICU.

Clinical Trial Description

The purpose of the study is to examine feasibility and acceptability of lower extremity neuromodulation in patients at risk of ICUAW. This is a proof Randomized controlled trial (RCT) study for prevention. Eligible participants will be recruited from Baylor St Luke's Medical Center (Houston, Texas). Participants will be randomized to intervention group (IG) or control group (CG). The entire cohort will receive daily neuromodulation in the lower extremity (Gastrocnemius muscle, Achilles tendon) up to 1 hour. The therapy will be provided with a neuromodulation device (Tennant Biomodulator PRO®, AVAZZIA, Inc.) that works on high voltage alternative pulsed current. The device will be functional for the IG and non-functional for the CG. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06238609
Study type	Interventional
Source	Baylor College of Medicine
Contact	Bijan Najafi, PhD
Phone	713-798-7538
Email	bijan.najafi@bcm.edu
Status	Recruiting
Phase	Phase 1
Start date	August 28, 2023
Completion date	August 28, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05543980` - Leg Heat Therapy in Elderly Individuals	Phase 2
Enrolling by invitation	`NCT03297632` - Improving Muscle Strength, Mass and Physical Function in Older Adults	N/A
Completed	`NCT04207359` - Effects of Creatine Supplementation in Breast Cancer Survivors	N/A
Completed	`NCT06216015` - Exercise Training and Kidney Transplantation	N/A
Completed	`NCT04076982` - Effect of Supplementary Dietary Protein (21g Per Day) on Lean Mass and Strength in Sedentary, Adult Vegetarians	N/A
Not yet recruiting	`NCT03662555` - Effect of Neuromuscular Electrical Stimulation Combined With Blood Flow Restriction on Muscular and Cardiovascular Function	N/A
Completed	`NCT02530723` - Functional Changes and Power Training in Older Women.	N/A
Completed	`NCT01704976` - SR-WBV Training for Frail Elderly in the Skilling up Stage	N/A
Completed	`NCT01743495` - CAPABLE for Frail Dually Eligible Older Adults	N/A
Completed	`NCT00183040` - HORMA: Hormonal Regulators of Muscle and Metabolism in Aging	Phase 2
Enrolling by invitation	`NCT06432062` - Investigation the Effect of Rectus Abdominis and Erector Spinae Muscle Fatigue on the Viscoelastic Properties of Thoracolumbal Fascia
Recruiting	`NCT05073224` - Muscle Function After Childbirth	N/A
Completed	`NCT04956705` - Vitamin D and Calcium Supplementation at Danish Nursing Homes	N/A
Recruiting	`NCT03810768` - Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Completed	`NCT00060970` - Evaluating Muscle Function After Ankle Surgery	N/A
Completed	`NCT04546048` - The Early Strength Training Program in Post-transplant Liver Cases	N/A
Completed	`NCT03628365` - Can Beta-Hydroxy-beta-Methylbutyrate Supplementation Counteract Muscle Catabolism in Critically Ill Patients?	N/A
Completed	`NCT05056298` - Effect of Insole Added to Exercise in Patients With Bilateral Flexible Flatfoot	N/A
Completed	`NCT02739464` - Effect of In-Patient Exercise Training on Length of Hospitalization in Burned Patients	N/A
Completed	`NCT05497960` - Vivo Prediabetes Study: Online, Live, and Interactive Strength Training for Older Adults With Prediabetes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms